Skip to main content

Table 2 Hypertension outcomes among the 454 Tanzanian adult study participants

From: Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study

Variable

HIV-negative

HIV-infected,

P-value

HIV-infected,

P-value

Proportion (%)

control

ART-naïve

versus

on ART

versus

Median [IQR]

(number = 153)

(number = 151)

control

(number = 150)

control

Hypertension a

25 (16.3%)

8 (5.3%)

0.003 b

43 (28.7%)

0.01

Systolic blood pressure

120 [110 to 130]

115 [110 to 120]

0.007

120 [110 to 137.5]

0.16

Diastolic blood pressure

75 [70 to 80]

75 [70 to 80]

0.04

80 [70 to 90]

0.11

Heart rate

73 [70 to 77]

74 [70 to 79]

0.35

74 [69.5 to 85]

0.18

Hypertension grade

  

P-value for trend

 

P-value for trend

Normal

66 (43.1%)

69 (45.7%)

 

49 (32.7%)

 

Prehypertension

62 (40.5%)

74 (49.0%)

0.16

58 (38.7%)

0.01

Grade 1 hypertension

20 (13.1%)

7 (4.6%)

 

33 (22.0%)

 

Grade 2 hypertension

5 (3.3%)

1 (0.7%)

 

10 (6.7%)

 
  1. aPrimary outcome: hypertension defined as average SBP >140 and/or DBP >90 and/or currently taking antihypertensive medications. bThroughout the tables, bolding has been used to indicate those p-values and odds ratios which were statistically significant. ART, antiretroviral therapy; IQR, interquartile range.